Drug ID: | NPD5277 |
Drug Name: | Salirasib |
Molecular Formula: | C22H30O2S |
Canonical SMILES: | C/C(=CCSc1ccccc1C(=O)O)/CC/C=C(/CCC=C(C)C)C |
Standard InCHI: | InChI=1S/C22H30O2S/c1-17(2)9-7-10-18(3)11-8-12-19(4)15-16-25-21-14-6-5-13-20(21)22(23)24/h5-6,9,11,13-15H,7-8,10,12,16H2,1-4H3,(H,23,24)/b18-11+,19-15+ |
Standard InCHIKey: | WUILNKCFCLNXOK-CFBAGHHKSA-N |
Max Developmental Stage: | Phase 2 |
Max Developmental Stage Source: | ChEMBL |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DNCL002573; DIB015318 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | 5469318 |
ChEBI | |
CAS Number |
Molecular Weight | 358.20 |
ALogP | 4.383 |
MLogP | 3.55 |
XLogP | 7.191 |
HDA | 2 |
HBD | 1 |
Rotatable Bonds | 15 |
TPSA | 62.6 |
RO5 Violation | 1 |